Skip to main content
Recall Canary
Isotretinoin 40 mg Capsules
← Back to all recalls
DRUG RECALLMODERATE

Isotretinoin 40 mg Capsules

Teva is recalling Isotretinoin 40 mg capsules due to superpotency and subpotency concerns that may affect treatment efficacy or safety.

What to do

Contact your pharmacist or healthcare provider to verify if your medication is affected and to discuss alternative treatment options. Do not stop taking your medication without consulting your doctor.

Posted
Updated
Recall No.
D-0446-2026
Agency
Firm
Teva Pharmaceuticals USA, Inc
Recall ID
98275
Status
ONGOING

Why it was recalled

Superpotent and Subpotent

How to identify it

UPC 100075305 100075512 100076103

Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).

Where it was sold

Distributed in US-FL, US-MS, US-OH.

Other recent recalls from Teva Pharmaceuticals USA, Inc

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-02 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification